What is Kubota Pharmaceutical Holdings Co Gross Margin %?
Kubota Pharmaceutical Holdings CoTSE:4596 49 Gross Margin % is 67.64% as of Mar. 2026, which is 35% above its 10-year median of 49.98. GuruFocus rates TSE:4596 with a GF Score™ of 49/100 and a GF Value™ of 円39.99 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 733 Biotechnology companies, Kubota Pharmaceutical Holdings Co ranks worse than 62.07% on this metric.
Kubota Pharmaceutical Holdings Co (TSE:4596) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Kubota Pharmaceutical Holdings Co had a gross margin of 67.64% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Kubota Pharmaceutical Holdings Co Gross Margin % Related Terms
Kubota Pharmaceutical Holdings Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kubota Pharmaceutical Holdings Co Gross Margin % Chart
TSE:4596 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Kubota Pharmaceutical Holdings Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kubota Pharmaceutical Holdings Co Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kubota Pharmaceutical Holdings Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Kubota Pharmaceutical Holdings Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Kubota Pharmaceutical Holdings Co (TSE:4596) has a Gross Margin % of 67.64% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Kubota Pharmaceutical Holdings Co and its competitors. This is 35% above median its historical median of 49.98. According to the industry distribution chart, Kubota Pharmaceutical Holdings Co ranks #455 out of 733 companies in the Biotechnology industry, placing it in the top 62.1%.
Is Kubota Pharmaceutical Holdings Co's Gross Margin % too high?
Kubota Pharmaceutical Holdings Co's current Gross Margin % of 67.64% is 35% above median its 10-year median of 49.98. The Biotechnology industry median Gross Margin % is 60.90. Kubota Pharmaceutical Holdings Co's value of 67.64% is 11.1% above this industry median. Based on the distribution chart, Kubota Pharmaceutical Holdings Co ranks #455 out of 733 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Kubota Pharmaceutical Holdings Co has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kubota Pharmaceutical Holdings Co's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kubota Pharmaceutical Holdings Co ranks #455 out of 733 companies for Gross Margin %. This places Kubota Pharmaceutical Holdings Co in the lower half of its industry. The industry median Gross Margin % is 60.90. Kubota Pharmaceutical Holdings Co's value of 67.64% is 11.1% above this benchmark. While the company's 10-year median is 49.98 vs. the industry median of 60.90, Kubota Pharmaceutical Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.90, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kubota Pharmaceutical Holdings Co's current Gross Margin % of 67.64% is 11.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Kubota Pharmaceutical Holdings Co and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kubota Pharmaceutical Holdings Co's current Gross Margin % is 67.64%, which is 35% above median its own 10-year median of 49.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kubota Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co (TSE:4596) is currently considered Significantly Overvalued. The stock's GF Value™ is 円39.99, compared to a current price of 円55.00 — trading 37.5% above its estimated fair value. The current Gross Margin % is 67.64%, which is 35% above median its 10-year median of 49.98 and 11.1% above the Biotechnology industry median of 60.90. Kubota Pharmaceutical Holdings Co's overall GF Score™ is 49/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Kubota Pharmaceutical Holdings Co (TSE:4596), the current Gross Margin % is 67.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kubota Pharmaceutical Holdings Co (TSE:4596) Overvalued in 2026?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co stock appears to be overvalued.
The current stock price of 円55.00 is trading 37.5% above its estimated GF Value™ of 円39.99.
GuruFocus considers Kubota Pharmaceutical Holdings Co to be Significantly Overvalued.
Key valuation signals for TSE:4596:
Gross Margin %: 67.64% (35% above median its 10-year median of 49.98)
GF Value™: 円39.99 vs. price of 円55.00 (37.5% above fair value)
Industry Position: 11.1% above the Biotechnology median (#455 of 733)
No single metric tells the full story. See the TSE:4596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kubota Pharmaceutical Holdings Co Business Description
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.
49GF Score
Get the complete analysis for TSE:4596
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4596 has been successfully added to your 
